InsB (9-23) is an insulin B-chain peptide that binds to a class II histocompatibility complex (MHC) allele called I-Ag7. InsB (9-23) can be used to treat a number of autoimmune related diseases like Type 1 diabetes.
InsB 9-23 is a synthetic peptide fragment corresponding to amino acids 9 through 23 of the insulin B chain. As a well-characterized epitope, it holds significant importance in immunological and biochemical research, particularly in the study of autoimmune responses associated with type 1 diabetes. The sequence is highly conserved and recognized for its role in T cell activation, making it a valuable tool for dissecting antigen-specific immune mechanisms. Its defined structure and immunological relevance render it suitable for a wide range of experimental applications, from basic immunology to translational research focused on autoantigen recognition.
Epitope mapping: InsB 9-23 is widely used in epitope mapping studies to identify peptide regions within the insulin molecule that are recognized by autoreactive T cells. Researchers utilize this fragment to pinpoint immunodominant determinants involved in autoimmune processes, enabling detailed characterization of T cell receptor specificity and antigen presentation pathways. Such mapping is crucial for understanding the molecular basis of autoimmune recognition and for developing targeted strategies to modulate immune responses.
Autoimmunity research: The peptide is instrumental in investigating the pathogenesis of type 1 diabetes, where autoreactive T cells target pancreatic beta cells. By incorporating InsB 9-23 into in vitro and in vivo assays, scientists can monitor the activation, proliferation, and cytokine profiles of insulin-reactive T lymphocytes. These studies provide insights into the mechanisms driving beta cell destruction and facilitate the development of novel approaches to immune tolerance induction.
Antigen presentation assays: InsB 9-23 serves as a model antigen in studies of major histocompatibility complex (MHC) class II presentation. Its well-defined sequence allows for controlled experiments assessing peptide binding affinity, MHC restriction, and antigen processing. Such assays are pivotal for elucidating the molecular interactions between peptide antigens, MHC molecules, and T cell receptors, advancing the understanding of adaptive immune recognition.
Peptide-based immunotherapy development: The defined structure and immunogenic properties of this peptide make it a candidate for evaluating peptide-based immunomodulatory strategies. Researchers employ InsB 9-23 in preclinical models to assess the efficacy of tolerogenic peptides or altered peptide ligands in modulating immune responses. These investigations support the rational design of peptide therapeutics aimed at restoring immune tolerance in autoimmune conditions.
Assay development and standardization: Due to its reproducible immunological activity, InsB 9-23 is frequently used as a reference peptide in the development and validation of immunoassays. Its inclusion in experimental protocols ensures assay consistency and facilitates the comparison of immune responses across different studies. This role is especially valuable in multicenter research efforts and in the standardization of assays for immune monitoring in diabetes research.
2. Cationic cell-penetrating peptides are potent furin inhibitors
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More